Page last updated: 2024-10-29

ketoprofen and Obesity

ketoprofen has been researched along with Obesity in 1 studies

Ketoprofen: An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.
ketoprofen : An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kang, NH1
Mukherjee, S1
Jang, MH1
Pham, HG1
Choi, M1
Yun, JW1

Other Studies

1 other study available for ketoprofen and Obesity

ArticleYear
Ketoprofen alleviates diet-induced obesity and promotes white fat browning in mice via the activation of COX-2 through mTORC1-p38 signaling pathway.
    Pflugers Archiv : European journal of physiology, 2020, Volume: 472, Issue:5

    Topics: 3T3-L1 Cells; Adipose Tissue, White; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenas

2020